| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9267647 | Joint Bone Spine | 2005 | 5 Pages |
Abstract
Conclusion. - Autoantibody induction was far less common in our patients than in the population studied by De Rycke et al. [Arthritis Rheum. 48 (2003) 1015], who found ANA in 88.6% and antibodies to double-stranded DNA in 17.1% of 35Â patients taking infliximab without methotrexate. Methotrexate may reduce the risk of autoantibody induction and disimmunity associated with infliximab therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Jérémie Sellam, Yannick Allanore, Frédéric Batteux, Chantal Job Deslandre, Bernard Weill, André Kahan,